Advanced Search
Published: Aug 5, 2020 DOI: 10.21769/BioProtoc.5005 Views: 4477
Reviewed by: Molly M. LeungZhenying Liu Timo A Lehti
Abstract
This protocol describes a step by step method for heterologous expression of SARS-CoV2 Nucleocapsid (N) protein in Escherichia coli. Moreover, this protocol includes steps to purify the N protein to high purity and homogeneity. Thus, purified protein can be used for ligand binding assays and other biochemical experiments.
Keywords: COVID-19Background
Since its detection in late 2019 in Wuhan, China, SARS-CoV2 infections have been rampant around the world (Wu et al., 2020). In an effort to follow the course of early infections, the nucleocapsid protein (N) was used along with the spike protein (S) in serological assays to monitor the course of early infections in the New York area. N is one of the most highly expressed viral protein, and therefore a good target to follow. To facilitate these assays, a purification protocol was developed for N and used successfully in these studies.
Materials and Reagents
Equipment
Procedure
Category
Microbiology > Heterologous expression system > Escherichia coli
Molecular Biology > Protein > Expression
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Share
Bluesky
X
Copy link